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In order to establish criteria for the Serodiagnosis of 
foamy virus infections we investigated the extent to 
which sera from iofected individuals of human and 
primate origin react with structural and non-structural 
virus proteins in immunoblot assays. Using lysates from 
infected cells as the source of virus antigen, antibodies 
were preferentially detected against the Gag proteins 
and the non-structural Bet protein. Both the Gag 
precursor molecules of70 and 74K apparent Mr and the 
cytoplasmic 60K Mr Bet protein were found to be 
phosphorylated, the latter being synthesized in large 
amounts in infected cells. Rahbit antiserum raised 
against recombinant human foamy virus (HFV) Gag 
major capsid protein cross-reacted with foamy viruses of 
chimpanzee, gorilla, orang-utan, rhesus monkey and 
Introduction 
The foamy viruses are a poorly characterized subgroup 
of the Retroviridae (Aguzzi, 1993; Loh, 1993; Flügel, 
1993; Rethwilm, 1994). Foamy viruses are frequently 
found in wild and captive monkeys, great apes, felines, 
bovines and occasionally other mammalian species 
(Aguzzi, 1993; Loh, 1993). As revealed by immuno-
fluorescence assays, the serological prevalence in 
monkeys has been reported to be high, reaching 70% or 
more (Hooks & Gibbs, 1975; Hooks & Detrick-Hooks, 
1981). Foamy viruses have been isolated from healthy 
animals, as weil as from animals with various diseases, 
but have never been convincingly associated with a 
distinct pathological condition (Aguzzi, 1993; Loh, 1993; 
Tbe nucleotide sequence data reported bere have been submitted to 
the EMBL database and assigned accession numbers X79000 (pA65) 
and X79001 (p20A). 
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Mrican green monkey origin. This was reßected by a 
broad cross-reactivity of the respective monkey sera to 
the Gag proteins of the various foamy virus isolates. 
Cross-reactivity of antisera against the Bet protein was 
restricted to viruses from man and the great apes. 
Recombinant Gag and Bet proteins expressed in 
prokaryotes or in insect cells were readily recognized by 
foamy virus-positive primate sera. Screening serum 
samples from chimpanzees with HFV Gag and Bet 
proteins expressed by recombinant baculoviruses 
revealed that 18 out of 35 (52%) were positive for Gag 
antibodies. Of these, 13 (72 o/o) showed antiborlies 
against the Bet protein, indicating that Bet antigen is of 
value in sero1ogical screening for foamy virus infections. 
M. 0. McClure et al., unpublished results). Although 
highly cytopathic in tissue culture, foamy viruses have 
been regarded as benign passengers in their natural hosts 
(Coffin, 1990). 
In 1971 a human foamy virus (HFV71) was isolated 
from a Kenyan patient suffering from nasopharyngeal 
carcinoma (Achong et al., 1971). Although further foamy 
virus isolates from human tissue have been reporterl 
(Y oung et al., 1973; Stancek et al., 1975; Cameron et al., 
1978; Werner & Gelderblom, 1979), HFV71 is still the 
only human isolate available for research. 
Serological surveys for foamy virus antiborlies in the 
human population have led to controversial results. 
While Achong & Epstein (1978), Muller et al. (1980) and 
Loh et a/. (1980) reported HFV seropositivity in East 
African and Pacific island populations, respectively, 
Brown et al. (1978) could not find HFV antiborlies in 
sera originating from East Africa and the U.S.A. More 
recently, Mahnke et a/. (1992) reported antiborlies to 
HFV Gag and Env proteins in 1 to 2 °/o of European sera 
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and in 6 to 7 % of sera originating from tropical Africa, 
indicating a possible worldwide prevalence of human 
foamy virus infections. The latter study was carried out 
by using HFV Gag and Env antigen expressed in 
prokaryotes (Bartholomä et al., 1992; Mahnke et al., 
1990) in ELISA and immunoblot assays, with antigen 
from virus-infected ceUs as a confirmatory assay in 
selected cases. However, the immunoblot assays 
presented by Mahnke et al. (1992) showed a plethora of 
weak bands, appearing to make the discrimination 
between specific and non-specific reactions a matter of 
chance. This study has therefore been criticized for 
methodological inconsistencies (Neumann-Haefelin et 
al., 1993). 
Since recent · immunological studies suggested an 
aetiological role for foamy virus infection in motor 
neuron disease (amyotrophic lateral sclerosis; Westarp et 
al., 1992) andin Graves' disease (Wiek et a/., 1993; R. 
Emanoil-Ravier, personal communication) we attempted 
to define the normal pattern of foamy virus proteins 
recognized by positive sera in immunoblot assays, in 
order to establish criteria for foamy virus serodiagnosis. 
Methods 
Cells and viruses. Babyhamster kidney cells (BHK-21) and primary 
diploid human embryonie Jung fibroblasts (HEL) were obtained from 
the ATCC and from Dr F. Harms (Würzburg, Germany), respectively. 
Cells were grown in MEM supplemented with 5% fetal calf serum and 
antibiotics. HFV was a gift of Dr M. A. Epstein (Bristol, U.K.), the 
simian foamy viruses (SFV) types 1, 2, 3, 5, 6, 7 and 8 were obtained 
from the ATCC. The isolation of SFVpp from an orang-utan called 
Dodo (London Zoo, U.K.) will be reported elsewhere (M. 0. McClure 
et al., unpublished results). For the isolation of SFVgg, peripheral 
lymphocytes were prepared from heparinized blood from a gorilla 
called Rann (a gift of Dr H. M. McClure, Yerkes Primate Research 
Center, Lawrenceville, Ga., U.S.A.) and cocultivated with the human 
T lymphoid cellline SupT 1. The culture supernatant was monitared for 
reverse transcriptase activity (Daniel et al., 1985) on a weekly basis and 
gave a positive reading on day 28 of culture. Examination of the cell 
pellet by electron microscopy revealed virus particles with foamy virus 
morphology (data not shown). The virus was subsequently grown on 
Vero cells and virus aliquots were stored in liquid nitrogen. 
Sera. The HFV -reactive human serum C2 and the orang-utan sera 
have been described previously (Netzer et al., 1990; Neumann-Haefelin 
et a/., 1993; M. 0. McClure et a/., unpublished results). Chimpanzee 
sera were obtained from Dr H. Berthold (Freiburg, Germany), Dr G. 
Wiek (lnnsbruck, Austria) and Dr J. Lewis (London, U.K.). Gorilla 
sera were a gift of Dr H. M. McClure. Rhesus monkey sera wcre a gift 
of Dr C. Stahl-Hennig and Dr S. Stille-Siegener (Deutsches 
Primatenzentrum, Göttingen, Germany). African green monkey sera 
were derived from monkeys of the colony at the Institut für Hygiene 
und Mikrobiologie in Freiburg, Germany. The rabbit antisera 
generated against recombinant HFV Gag, Bel-l and Bel-2 proteins 
have been described previously (Aguzzi et al., 1993; Baunach et al., 
1993). 
Cloning of cDNA. Total RNA was prepared from BHK-21 cells, 
lytically infected with HFV for 3 days by the method of Chirgwin et al. 
(1979). Poly(A)-positive RNA was selected on an oligo(dT) column 
and 5 jlg were used to synthesize cDNA by the method of Gubler & 
Hoffman (1983) using a commercial kit (Promega). The cDNA was 
blunt-ended with T4 DNA polymerase and inserted into a Smai-cut 
and dephosphorylated pUC19 vector. After transformation of com-
petent DH5oc MAX Efficiency cells (Gibco BRL), bacterial colanies 
were screened by hybridization to a 32P-labelled EcoRI-BstEII 
fragment from the 3' HFV genome as described by Grunstein & 
Hogness (1975). Colanies (220) displaying a strong signal were further 
characterized by restriction enzyme digestion for !arge inserts. In 
addition, the plasmid clones were analysed by EcoRI-Bglii digestion to 
detect the splicing event leading to the bet mRNA. Out of 38 cDNA 
clonesthat extended 5' to the Bel-l coding region, 21 showed a 0·79 kb 
EcoRI-Bglll fragment (instead of the 1·09 kb EcoRI-Bg/Il fragment 
in the unspliced version) characteristic of the bet splicing event. The 
nucleotide sequences of the viral inserts of the clones pA65 and pB52 
were determined by dideoxynucleotide chain tennination sequencing 
(Sanger et a/., 1977). The A20 clone was isolated by screening a cDNA 
library synthesized from poly(A)-positive mRNA from SFV-1-infected 
cells with a probe from the 3' region ofthe SFV-1 genomc as described 
previously (Mergia, 1994). The nucleotide sequence of the viral insert 
was determined after subcloning into the pUCI18 vector as reported 
(Mergia et al., 1991). 
Expression ofGag and Bet in eukaryotic expression vectors. The pA65 
cDNA clone has a 12 bp in-frame deletion. After repair of this deletion 
by exchange of a 0·66 kb Bg!II-Ajlll fragrnent derived from the 
infectious molecular clone pHSRV (Rethwilm er al., 1990), the bet 
coding sequences ofpA65 (HFV) and p20A (SFV-1) were inserted into 
simian virus 40 (SV 40) promoter-directed expression vectors (Rethwilm 
et al., 1991; Mergia et al., 1991). This gave rise to pSbet (HFV) and 
pSV20A (SFV -1 ). 
The complete HFV gag sequence, as a 2·54 kb Mstll fragment from 
pHSRV (Fig. 1) and the complete HFV bet coding sequence from the 
repaired clone pA65 were inserted into the Smal site of the baculovirus 
transfer vector pAcCL29-1 (Livingston & Jones, 1989) by blunt-end 
ligation. Following cotransfection with AcRP23-lacZ virus DNA 
(Possee & Howard, 1987) in Spodoptera frugiperda (Sf9) cells, 
recombinant baculoviruses were isolated and plaque-purified as 
described previously (Matsuura et al., 1987). 
Expression of Gag and ßet in prokaryotic expression vectors. The 
HFV bet coding sequence, lacking the amino-terminal 15 codons, was 
excised as an EcoRI-Afiii fragment from pA65 and inserted into the 
Stui and Smai site of the bacterial overexpression vectors pROS 
(Ellinger et al., 1989) and pGEX-2T (Smith & Johnson, 1988), 
respectively, after treating the ends with the Klenow fragrnent of DNA 
polyrnerase I. In a similar fashion, the SFV -1 bet coding region, lacking 
the amino-terminal 24 codons, was excised as a Bg/II-Hincii fragment 
from pSV20A and inserted into the EcoRV and Smal site ofpROS and 
pGEX-3X, respectively. The correct insertion of the bet sequences in 
frame with the lacZ (ß-galactosidase; PGAL) and glutathione S-
transferase (GST) genes of pROS and pGEX, respectively, was verified 
by nucleotide sequencing. The expression of HFV gag sequences in the 
pROS vector has been described previously (Aguzzi et a/., 1993). The 
expression strategy of the recombinant proteins is shown in Fig. I. 
Preparation of virus antigen and immunoblot assays. For the 
preparation of antigen, all virus isolates were cultivated on primary 
HEL cells. Infected cells were harvested when approximately 30% of 
the culture showed typical giant cell c.p.e. After washing in PBS the 
cells were lysed in detergent buffer [20 mM-Tris-HCl pH 7·4, 0·3 M-
NaCl, 1% sodium desoxycholate, 1% Triton X-100, (}1% SDS, 
0·02% sodium azide, 1 rnM-PMSF, 20 ~M-4-amidino-PMSF, 1 JlM-
pepstatin A and 10 ~M-protease inhibitor E64 (Sigma)}. Following 
measurement of the protein content with a commercial assay (Sigma), 
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Fig. 1. Fragments of the HFV and SFV -1 genome expressed in bacteria 
and by recombinant baculovirus. (a) Expression of the HFV gag gene 
fragments 1 to 3 in the pROS vector has been described recently 
(Aguzzi et a/., 1993). In addition, the complete HFV gag gene was 
inserted into a recombinant baculovirus as a Mstll fragment. (b) The 
HFV bet coding sequence was cloned into baculovirus as a Nhei-Ajlll 
fragment and into the pROS and pGEX-2T prokaryotic expression 
vectors as an EcoRI-Aflll fragment. The SFV-1 bet coding sequence 
was inserted into pROS and pGEX-3X vectors as a Bg/11-Hincll 
fragment. The positions of the matrix protein (MA), major capsid 
protein (CA) and nucleocapsid protein (NC) are indicated. 
equal amounts ofprotein were separated by 12·5% SOS-PAGE and 
serni-dry b1otted onto a nitrocellu1ose mernbrane (Schleicher & Schüll). 
The rnernbranes were blocked in Tris-buffered saline (20 mM-Tris-HCI 
pH 7·6, 137 mM-NaCI; TBS) containing 3% non-fat dried milk (TBS-
M). Membranes were incubated with primate sera diluted I :200 or 
with rabbit sera diluted 1:500, in TBS-M for 60 min. Following several 
washes in TBS containing 0·5% Tween 20, the membranes were 
incubated with the appropriate peroxidase-coupled secondary antibody 
(Dako) and washed .again. The immunostain was developed using the 
ECL chemiluminescence detection system (Amersham). 
BHK-21 cells were transfected with bet expression vector ONA and 
lysates of transfected ce11s were harvested for immunoblot analysis as 
described. recently (Baunach et a/., 1993). Gag and Bet proteins 
expressed in bacteria and insect cells were purified by preparative 
SOS-PAGE to greater than 90% purity as described previously 
(Netzer et a/., 1993). In immunoblot assays 100 ng of purified protein 
per 1ane was used. 
Radioimmunoprecipitation assays (RIPA). HFV-infected BHK-21 
cells were metabolically Iabelied with either 100 J.1Ci/ml [36S]methionine 
(Amersham) or 170 J.1Cijml [32P]orthophosphate (Amersham) for 4 h. 
After washing, the cells were lysed in ice-cold detergent buffer. The 
lysates were cleared by incubation with an excess of normal rabbit 
serum for 2 h at 4 °C, followed by incubation with staphylococcal 
protein A-:-Sepharose (PAS; Pharmacia) for I h and centrifugation at 
10000 g for 2 min. The clarified supernatant was then immuno-
precipitated with Gag and Bel protein-specific rabbit antisera for 2 h at 
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4 oc. The immune complexes were collected with PAS, washed six 
times with detergent buffer, resolved by 12·5% SOS-PAGE, and 
exposed to X-ray film. 
Results 
Characterization of HFV and SFV-1 Bet and Gag 
· proteins 
In a previous study, a foamy virus-encoded intracellular 
protein with an Mr of 60K was found tobe recognized by 
foamy virus-positive primate sera (Netzer et al., 1990). 1t 
has been specu1ated that this protein might represent the 
Bet protein (Baunach et al., 1993). To elucidate the 
nature of the protein and to clarify whether it is identical 
to the Bet protein, we synthesized cDNA from the 
mRNA of cells that were lytically infected with HFV. 
More than 50% of the cDNA clones that were not 
prematurely terminated showed the bet splicing event. 
Two different types of bet cDNA clones were identified 
(pB52 and pA65) and one representative of each was 
chosen for nucleotide sequencing. Both clones start in 
the vicinity ofthe HFV internal start site oftranscription 
(Löchelt et al., 1993). Whereas pB52 was derived from an 
mRNA singly spliced from the bel-l open reading frame 
(ORF) into the be/-2 ORF, the clone pA65 represented a 
double-spliced mRNA from which an additional intron 
was spliced out. This splicing event has been described 
recently to be characteristic for transcripts starting at the 
foamy virus internal promoter (Löchelt et al., 1994). In 
both clones the first A TG codon was from the bel-l 0 RF. 
In a similar way to the HFV bet cDNAs clone, phage 
lambda clone 20A starts in the vicinity of the SFV -1 
internal promoter (Mergia, 1994) and shows an identical 
splicing pattern to the HFV bet clone pA65, using splice 
sites conserved in all foamy virus genomes sequenced so 
far (Flügelet a/., 1987; Mergia et al., 1991; Kupiec et al., 
1991; Renne et al., 1992; Herchenröder et al., 1994). The 
SFV-1 bet sequence starts with the ORF-1 ATG and is 
spliced into the ORF-2 frame after 93 codons ofORF-1. 
The HFV bet cDNA from clone pA65 and the SFV-1 
bet cDNA from 20A were inserted into eukaryotic 
expression vectors under control of the SV 40 enhancer-
promoter sequences. Comparison of lysates from BHK-
21 cells, either transfected with the HFV Bet-eneoding 
plasmid pSbet or infected with HFV, in an immunoblot 
assay with Bel-l- and Bel-2-specific rabbit antisera and 
with a HFV -positive human serum, revealed the 60K 
protein reactive with the sera in lysates from infected 
cells to be of the same Mr as the protein encoded by 
pSbet, indicating that it is Bet (Fig. 1 a). Immunoblot 
analysis oflysates from cells, transfected with the SFV-1 
Bet-expressing plasmid pSV20A or infected with SFV-1, 
with SFV-1-positive rhesus monkey serum gave an 
analogaus result (data not shown). 
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Fig. 2. (a) Identification ofthe HFV Bet protein. Lysates from BHK-21 cells either transfected with an expression plasmid (pSbet) for 
the A65 cDNA clone or infected with HFV were reacted with rabbit sera directed agairrst the HFV bei-1 and be/-2 ORFs or with human 
anti-HFV-positive seruminan immunoblot assay. (b) Phosphorylation ofBel-1 and Bet. HFV-infected BHK-21 cells were Iabeiied with 
[32P]orthophosphate. The proteins were then precipitated with either Bel-l- or Bel-2-specific rabbit antisera, or preimmune rabbit 
serum, and resolved by SDs-PAGE. Both antisera precipitated the 60K Bet protein. In addition, Bel-l antiserurn also precipitated the 
36K Bel-l protein. Lane M contains Mr markers. (c) Phosphorylation of the Gag precursor 70/74K proteins. HFV-infected BHK-21 
cells were metabolically Iabelied with (32f}orthophosphate or [3r.SJmethionine, the virus Gag proteins were precipitated with rabbit 
antisera generated against different protein domains from the HFV gag ORF (Fig. I) and resolved by SOS-PAGE. 
The HFV Bel-l protein has been shown to be 
phosphorylated (Venkatesh et al., 1993). Since the Bet 
protein of HFV contains 88 amino acids of the bel-l exon 
at its amino terminus, we asked whether Bet might also 
be a phosphoprotein. As shown in Fig. 2(b), phosphate-
labelled Bet can be precipitated from HFV -infected cells 
with either Bel-l- or Bel-2-specific antisera. However, 
whether Bet phosphorylation is due solely to its Bel-l 
component cannot be deduced from this experiment, 
since the bel-2 ORF also possesses potential phosphoryla-
tion sites. 
The HFV gag ORF is expressedas precursor molecules 
of 70K and 74K (Aguzzi et al., 1993). To investigate 
whether this Mr difference might be due to phosphoryla-
tion, we Iabelied HFV-infected BHK-21 cells with 
[32P]orthophosphate or [35S]methionine and precipitated 
the Gag proteins with rabbit antisera generated against 
different domains of the Gag protein. As shown in Fig. 
2(c), both Gag precursor molecules were found to be 
phosphorylated to approximately the same extent. 
lnterestingly, precipitation of both the 32P- and 35S-
labelled 70K molecule was always found to be less 
effective with the Gag3 antiserum, which was generated 
against the carboxy-terminal gag ORF (Fig. 2c). 
Cross-reactivity of primate sera to different foamy virus 
isolates 
There have been confticting reports concerning the 
prevalence of foamy viruses in the human population 
(see above). We therefore set out to determine which 
virus proteins are readily recognized by foamy virus-
positive sera in an immunoblot assay. Since human sera 
that arepositive for foamy viruses are scarce (we know 
of only two, both resulting from accidental infection; 
Neuman-Haefelin et al., 1983, 1993) we used the sera of 
great apes and monkeys. Previous studies on the 
serological prevalence of foamy viruses among humans 
rely on virus antigen from one single isolate obtained 
from human tissue more than 20 years ago (Achong et 
al., 1971) and, moreover, some retroviruses are known to 
show considerable variation in their antigenic proteins 
(Vaishnav & Wong-Staal, 1991). Thus, the extent to 
which foamy virus-positive primate sera reacted with 
viruses originating from different species would de-
termine the potential of a given virus antigen to identify 
infections with distantly related viruses in a serological 
assay. To analyse this, HEL cells were infected with HFV 
(isolated from a human source), SFV-1 (macaque 
monkey), SFV-2 (macaque monkey), SFV-3 (African 
green monkey), SFV-5 (galago), SFV-6 (chimpanzee), 
SFV-7 (chimpanzee), SFV-8 (spider monkey), SFVpp 
( orang-utan) and SFV gg (gorilla). Lysates derived from 
productively infected cells were then subjected to 
immunoblot analysis with foamy virus-positive sera 
from human, chimpanzee, orang-utan, gorilla, rhesus 
monkey and African green monkey, as weil as with 
rabbit sera generated against recombinant HFV Gag, 
Bel-l and Bel-2 protein. Representatiye immunoblots are 
shown in Fig. 3. 
The proteins of the various viruses predominantly 
recognized by the homologaus sera were the two Gag 
precursor molecules and the Bet protein. The human 
serum detected the chimpanzee virus (SFV-6 and SFV-7) 
Gag and Bet proteins equally as weil as the respective 
HFV proteins, demonstrating the close relationship of the 
(a) 
(h) 
(c) 
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(e) 
(j) 
(g) 
(h) 
(i) 
p7017~ag 
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p7017~ag 
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p7017~ag 
p6ohet 
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Fig. 3. Immunoblots demonstrating the serological cross-reactivity 
against Gag and Bet proteins of primate foamy viruses. Lysates from 
HEL cells infected with the HFV isolate and SFV from macaque 
monkeys (types 1 and 2), African green monkey (type 3), prosimian 
galago (type 5), chimpanzee (types 6 and 7), New World spider monkey 
(type 8), gorilla (SFVgg) and orang-utan (SFVpp) were reacted with 
foamy virus-positive sera from human (a), chimpanzee (b), gorlila (d), 
orang-utan (e), rhesus monkey (f) and African green monkey (g), as 
weil as witb antisera against recombinant HFV CA (h) and Bel-l 
protein (1). In (c) the lysates were reacted with a foamy virus-negative 
chimpanzee serum. 
human and chimpanzee viruses (Nemo et al., 1978; 
Herchenröder et al., 1994). SFVgg proteins were less well 
detected. Only a weak cross-reactivity was observed with 
SFVpp and SFV-1 to SFV-3 Gag, and the Bet proteins 
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of these viruses were not detected by this serum (Fig. 3 a). 
The chimpanzee sera (Fig. 3 b) recognized Gag and Bet 
proteins of HFV, SFV-6 and SFV-7 and showed a 
broader cross-reactivity than the human serum to the 
Gag proteins of most virus isolates. Viral proteins in 
SFV -5- and SFV -8-infected cells were not recognized by 
any of the sera used. However, this being due to a Iack 
of virus antigen seems unliJcely since the celllysates were 
prepared when foamy virus c.p.e. was prominent. SFV-
5 and SFV-8 were isolated from a prosimian and a New 
World monkey, respectively (Hooks & Gibbs, 1975). 
Therefore, a Iack of cross-reactivity of our sera to these 
presumably distantly related viruses may explain the 
result. The gorilla serum (Fig. 3d) recognized the Gag 
precursors of HFV, the chimpanzee viruses and SFV-1. 
Only weak reactivity with SFV -2, SFV -3 and SFVpp 
Gagproteins was found, whereas the Bet proteinwas not 
detected with any lysate. In addition, this serum 
recognized proteins of around 130K. The orang-utan 
serum (Fig. 3e) also reacted well with a protein of 
approximately 130K. However, of the other virus 
proteins, only the Gag precursors of SFVpp and, to a 
weaker extent, of HFV, SFV-1, SFV-6, SFV-7 and 
SFV gg were detected. The rhesus monkey serum (Fig. 3 /) 
reacted weil with the Bet protein of SFV -1 and only 
barely with the SFV -2 Bet. A strong reaction was also 
observed with the Gag proteins of SFV-1, SFV-2 and 
SFV-3, whereas the respective proteins ofHFV, SFV-6, 
SFV-7, SFVgg and SFVpp were less well detected. The 
serum from an African green monkey (Fig. 3 g) showed 
reaction to the Gag precursors of HFV, SFV-2, SFV-3, 
SFV gg and SFVpp, whereas the respective proteins of 
SFV -1 and the chimpanzee viruses were only barely 
detected. The Bet protein was not recognized by this 
serum. 
A rabbit hyper-immune serum directed against the CA 
domain of HFV (Gag2 in Fig. 1) reacted with the Gag 
proteins of viruses isolated from the human (HFV), apes 
(SFV-6, SFV-7, SFVgg and SFVpp) and with SFV-1 and 
SFV-3 (Fig. 3h). A rabbit serum directed against 
recombinant HFV Bel-l detected the Bet proteins of all 
great apes (Fig. 3i). HFV, SFV-6, SFV-7 and SFVgg Bet 
proteins were of an apparent Mr of 60K, whereas the 
SFVpp Bet protein was approximately 4K smaller. In 
addition, this serum recognizes the Bel-l protein of the 
great ape foamy viruses and to a lesser extent the 
respective protein of SFV-1 and SFV-2. The SFVpp 
protein was found to be of higher electrophoretic 
mobility than the Bel-l proteins of the other higher 
pri'llates, corresponding to a 4K lower Mr. This indicated 
that the smaller Bet protein of this virus is caused by a 
smaller bel-l exon. The use of a Bel-2 ORF-specific 
rabbit antiserum revealed a similar Bet staining pattem 
to the Bel-l antiserum ( data not shown). 
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Fig. 4. Immunoblot of the purified recombinant HFV and SFV-1 
proteins. Human (a), chimpanzee (b) and rhesus monkey (d) foamy 
virus-positive sera and chimpanzee foamy virus-negative serum (c) 
were used. In (a) to (c), lysate from HFV-infected BHK-21 cells 
(BHK/virus) served as tbe positive control and PGal and GST proteins 
fused to HFV Bet were used. In (d), a lysate from SFV-1-infected 
BHK-21 cells was used as control and SFV-1 Bet was the fusionpartner 
of ßGal and GST. Sf9 and Sf9 I AcRP23-lacZ, lysates from uninfected 
and AcRP23-lacZ-infected Sf9 cells; BaGag and BaBet, purified 
recombinant protein from Sf9 cells infected with Gag8 Fv- and Bet8 pv-
expressing baculovirus, respectively. Tbe arrows indicate proteins in 
the range of 130K and 80K Mr in virus-infected cells recognized by 
some of the sera. 
Reactivity of foamy virus-positive primate sera to Gag 
and Bet proteins expressed in insect cel/s and in bacteria 
We examined the extent to which recombinant Gag and 
Bet proteins of HFV and SFV -1 could be used as a 
reliable source of antigen in serological assays. The 
recombinant proteins were used in an immunoblot assay 
with primate sera previously identified as containing 
foamy virus antiborlies by detection with virus antigen. 
As shown in the representative immunoblots of Fig. 4, 
foamy virus-positive human, chimpanzee and rhesus 
monkey sera recognized the HFV Gag protein expressed 
either in bacteria or in insect cells. Human and 
(a) (b) (c) (d) 
Fig. 5. Immunoblot of HFV Gag and Bet proteins, which were purified 
from insect cells infected with recombinant baculovirus with a human 
HFV-positive serum (a), foamy virus-negative chimpanzee serum (b), 
chimpanzee Gag-reactive serum (c) and chimpanzee serum reactive 
with Gag and Bet protein (d). 
chimpanzee sera reacted better with the HFV Gag 
portions corresponding to MA (Gagl) and CA (Gag2) 
protein, but the rhesus monkey sera showed no reaction 
with Gag I and reacted equally weil with Gag2 and Gag3 
antigen. The Bet protein displayed a more restricted 
reactivity. Bet antibody-positive human and chimpanzee 
sera detected the HFV Bet protein regardless of the 
vector system used (Fig. 4) but did not react with SFV-
1 Bet (data not shown). Conversely· Bet-positive rhesus 
monkey sera detected the SFV-1 Bet but did not react 
with HFV Bet (Fig. 4d). In addition, some sera reacted 
specifically with virus proteins with an Mr that was 
different to the 70j74K Gag precursor and the 60K Bet 
proteins in lysates of infected cells (Fig. 4b, d). These 
were in the range of 130K and 80K. 
Finally, we used the HFV Gag and Bet proteins 
purified from recombinant baculovirus-infected insect 
cells to screen a panel of chimpanzee sera by an 
immunoblot assay, taking advantage of the cross-
reactivity previously observed in assays with virus 
antigen from infected celllysates. Representative results 
are presented in Fig. 5. Of the 35 sera investigated, 18 
(52 o/o) reacted positive with Gag antigen. Of these, 13 
(72 o/o) also had antiborlies to the Bet protein. Reactivity 
against the Bet protein was always weaker compared to 
Gag reactivity, despite the fact that equal amounts of the 
respective proteins were loaded onto the gels. Notably, 
no unspecific bands were observed in this assay with any 
of the sera tested and discrimination between positive 
and negativeserawas easy to accomplish. 
Discussion 
Similar to the lentiviruses and the human T cellleukaemia 
virus-bovine leukaemia virus group of retroviruses, the 
foamy virus subgroup is characterized by the presence of 
accessory genes of suspecterl or proven regulatory 
function, in addition to the structural gag, pol and env 
genes (Mergia & Luciw, 1991 ; Cullen, 1991 ; Rethwilm, 
1994). Thus, the respective accessory proteins may give 
rise to a host immune response if exposed to the host 
immune system. Two non-structural accessory proteins 
have clearly been irlentifierl in the foamy virus system 
(Rethwilm, 1994). The nuclear 36K Bel-l trans-activator 
protein is a prerequisite for viral replication, while the 
cytoplasmic 60K Bet protein has been reporterl to be 
rlispensable for in vitro replication of the virus (Baunach 
et al., 1993; Yu & Linial, 1993). The use of hyper-
immune sera raiserl against recombinant Bet protein has 
inrlicated that the Bet protein might be a preferentially 
expresserl virus protein (Löchelt et al., 1991; Baunach et 
al., 1993). The cDNA cloning experiments on HFV 
mRNA rlescribed in this study provide strong evidence 
supporting this view. Restrietion enzyme analysis 
revealed more than 50% of the cDNAs that were not 
terminated early to be bet-specific. Both proteins Bel-l 
and Bet were found tobe phosphorylated. The functional 
consequences, if any, of this post-translational modifica-
tion are not known for either protein. 
The Gag precursor proteins of 70/74K were also 
found to be phosphorylated. 1t bad been suggested that 
phosphorylation might account for the difference in Mr 
of these two proteins (Batholomä et al., 1992; Flügel, 
1993). The data presenterl here indicate that this is 
probably not the case. Instead, the precipitation experi-
ments with an antiserum generated against the carboxy-
terminus or the HFV Gag protein suggest that the 70K 
molecule may either be a cleavage product of p74uau or 
that the protein was not synthesized to full Iength. 
Phosphorylation has also been demonstrated for the 
human immunodeficiency virus (HIV) and avian retro-
virus Gag proteins (Leis et al., 1989; Burnette et al., 
1993). However, any biological function of retrovirus 
Gag phosphorylation remains to be elucidated. 
The HFV Gag precursor has been reported to give rise 
to p32cA and p27MA capsid proteins (Aguzzi et a/., 1993; 
Bartholomä et a/., 1992). In addition, a pl5 capsid 
protein with RNA-binding properties, which may rep-
resent the foamy virus NC protein, has been reported for 
SFV-1 (Benzair et a/., 1986). When analysing infected 
cell extracts with foamy virus-positive primate sera or 
specific antisera raised in rabbits, we noticed that 
processing of the foamy virus Gag precursor seemed to 
be slow. For examp1e, p32cA was only occasionally 
observed by staining with a specific antiserum. Fur-
thermore, when virus harvested from cell-free super-
natant was purified by sucrose gradient centrifugation 
and analysed in immunoblot assays, we regularly 
observed the 70/74K Gag precursors, whereas the 
cleavage products were only rarely detected and Bet was 
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absent (data not shown). We do not yet know to what 
extent the slow processing of the foamy virus protease is 
responsible for the stability of the Gag precursor 
proteins. Certain1y culture conditions, type of host cells, 
anrl timepoint of harvest of celllysates anrl cell-free virus 
may inftuence the relative abunrlance ofthe Gag cleavage 
products. 
Antiborlies to the structural virus proteins Gag, Pol 
anrl Env prevail in retrovirus-infecterl primate hosts 
(Essex et al., 1985; Schochetman et al., 1989). In a 
previous sturly utilizing RIPA, a variety of immuno-
dominant foamy virus proteins has been characterized 
(Netzer et al., 1993). These include a 130K glycoprotein, 
most probably representing the env precursor (Giron et 
a/., 1993; Aguzzi et al., 1993) anrl the 70f74K and 60K 
proteins, now identified as the Gag precursor molecules 
anrl the Bet protein, respectively. In the immunoblot 
assays used in our sturly, antiborlies directerl against 
virus proteins other than Gag anrl Bet were only 
occasionally observerl. However, we cannot yet teil to 
what extent these antiborlies were rlirected against foamy 
virus Env or Pol proteins, since both ORFs give rise to 
precursors and cleaved proteins of almost similar size 
(Netzer et al., 1990, 1993; Aguzzi et al., 1993; Giron et 
al., 1993). The use of recombinant Pol and Env proteins 
as antigen in immunoblot assays might help to elucidate 
this point. With respect to antiborlies rlirected against the 
Env proteins we noticerl a marked difference in 
detectability depending on the assay system used. The 
same sera that previously recognized Env proteins in 
RIPA (Netzer et a/., 1990) rlid not detect these proteins 
in an immunoblot assay. Similar observations have been 
marle by others for foamy viruses (Giron et al., 1993) and 
HIV (Essex et al., 1985; Gaines et a/., 1987). 
In the previous study the rletection of the 70/74K 
proteins has been regarderl as particularly suitable for 
diagnostic purposes in RIPA (Netzer et al., 1990). We 
therefore investigated the extent to which primate sera 
reacterl with the Gagproteins of various foamy virus 
isolates. Our results demoostrate a broad cross-reactivity 
among foamy viruses and sera from infected Olrl World 
simians. This cross-reactivity was more pronounced with 
more closely related monkey species. However, rhesus 
anrl African green monkey sera rletected the Gagproteins 
from HFV anrl virus isolates from apes and vice versa. In 
contrast, the rletection of the Bet protein was found to be 
more restricted. While HFV Bel-l- anrl Bel-2-specific 
rabbit antisera rletected the Bel-l and Bet proteins of 
virus isolates from all great apes, the results from the 
human anrl chimpanzee sera indicate an ev~n closer 
relationship of the viruses isolated from these two 
species. 
There are limited nucleotide sequence data on primate 
foamy virus genomes available, which support our view 
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(Flügelet a/., 1987, 1990; Maurer et a/., 1988; Mergia et 
al., 1990; Kupiec et al., 1991; Renne et al., 1992; 
Herchenröder et al., 1994). Pol and Env proteins were 
found to be highly conserved among all foamy virus 
isolates. Unlike the immunodeficiency viruses (Vaishnav 
& Wong-Staal, 1991), the foamy virus Gag sequences are 
less weil conserved compared to Env sequences. How-
ever, closer inspection identified small clusters of highly 
conserved peptides distributed throughout the Gag 
protein (Schliephake & Rethwilm, 1994; data not 
shown). Antiborlies to these dustered sequences may 
account for the broad cross-reactivity against Gag 
proteins. With respect to the Bet protein, signific~mt 
amino acid similarity, leading to cross reactivity in 
serological assays, was only found between HFV and the 
chimpanzee virus (Herchenröder et al., 1994). 
When recombinant HFV Gag proteins expressed in 
bacteria were used as antigens in immunoblot assays, 
different portians of the Gag protein were recognized to 
different extents by foamy virus-positive sera. The 
recombinant protein corresponding to HFV CA showed 
the broadest antigenicity (Fig. 4). Similarly expressed Bet 
protein was also found to be a suitable antigen source in 
our detection system. However, since neither the immuno-
dominant epitopes of the foamy virus Gag protein, nor 
the inftuence on antigen recognition caused by phos-
phorylation of Gag and Bet are known, we used 
eukaryotically expressed HFV Gag and Bet proteins to 
screen chimpanzee sera for foamy virus antibodies. 
Compared to bacterial expression, the baculovirus 
system has the additional advantage of reducing the 
possibility of false positive reactions, often a problern 
with fusion proteins used in bacteria1 expression systems, 
altbough we did not observe such a reaction with any of 
the sera tested. 
Of the chimpanzee sera investigated, 52% had 
antiborlies to foamy virus Gag protein and 72% of these 
had antiborlies to Bet. While the percentage of captive 
chimpanzees identified by a serological assay to be 
infected with foamy virus is within the previously 
reported range (Hooks & Gibbs, 1975; Hooks & Detrick-
Hooks; 1981), the finding that a high percentage of Gag 
antibody-containing sera also reacted with the non-
structural Bet protein indicates that the Bet protein is not 
only synthesized in large amounts during virus rep-
lication in tissue culture, but may also be a preferentially 
expressed and immunogenic viral protein in the infected 
host. This observation is reminiscent of findings with 
HIV for which antibodies to the non-structural Nef 
protein were detected in up to 50% of infected 
individuals (Allan et al., 1985). 
The results reported here and previously (Netzer et al., 
1990) indicate that Gag-specific antibody response is a 
hallmark of foamy virus infection. In addition, it has 
been shown recently that Gag-specific immune response 
is responsible for the typical nuclear fluorescence that is 
observed when sera from infected individuals are reacted 
with foamy virus-infected cells in an immunofluorescence 
assay and which distinguishes the foamy viruses from all 
other known retroviruses (Teich, 1984; Neumann-
Haefelin et al., 1993; Loh, 1993, Schliephake & 
Rethwilm, 1994). The high percentage of Bet sero-
positivity among foamy virus-infected chimpanzes now 
points to a second protein which we suggest will be of 
value in screening human sera for foamy virus footprints. 
We thank H. Berthold, M. A. Epstein, F. Harms, H. M. McClure, 
C. Stahi-Hennig, S. Stille-Siegener, G. Wiek and J. Lewis for the gift of 
serum samples and viruses, 0. Herchenröder for communicating the 
SFVcpz sequence prior to publication and R. D. Possee and S. Ellinger 
for the gift of AcRP23-IacZ baculovirus and pROS vector, respectively. 
We also thank L. Dunster for reviewing the manuscript. This work was 
supported by grants from the DFG (SFB165) and the EU (PL931142). 
References 
AcHONG, B. G., MANSELL, P. W. A., EPSTEIN, M. A. & CUFFORD, P. 
(1971). An unusual virus in cultures from a human nasopharyngeal 
carcinoma. Journal of the National Cancer Institute 46, 299-307. 
AcHONG, B. G. & EPSTEIN, M. A. (1978). Preliminary sero-
epidemio)ogical studies on the human syncytial virus. Journal of 
General Virology 40, 17 5-181. 
AGUZZI, A. (1993). The foamy virus_ family: molecu1ar biology, 
epidemiology and neuropathology. Biochimica et biophysica acta 
1155, 1-24. 
AGuzzi, A., WAGNER, E. F., NETZER, K.-0., Bo1HE, K., ANHAUSER, I. 
& RETHWILM, A. (1993). Human foamy virus proteins accumulate in 
neurons and induce multinucleated giant cells in the brain of 
transgenic mice. American Journal of Pathology 142, 1061-1072. 
ALLAN, J. S., CouGAN, J. E., LEE, T.-H., McLANE, M. F., KANKI, 
P. J., ÜROOPMAN, J. E. & EssEx, M. (1985). A new HTLV /LAV 
encoded antigen detected by antibodies from AIDS patients. Science 
:Z30, 810-813. 
BARTHOLOMÄ, A., MURANYI, W. & FLÜGEL, R. M. (1992). Bacterial 
expression of the capsid antigen domain and identification of native 
gag proteins in spumavirus-infected cells. Virus Research 23, 27-38. 
BAUNACH, G., MAURER, B., HAHN, H., KRANZ, M. & .RirrHWILM, A. 
(1993). Functional analysis ofhuman foamy virus accessory reading 
frames. Journal of Virology 67, 5411-5418. 
BENZAIR, A. B., RßODES-FEUILLETTE, A., LASNERET, J., EMANOIL-
R.AVIER, R. & PERIES, J. (1986). Purification and cbaracterization of 
simian foamy virus type I structural core polypeptides. Archives of 
Viro/ogy 87, 87-96. 
BROWN, P., NEMO, G. & GAJDUSEK, D. C. (1978). Human foamy virus: 
further characterization, seroepidemiology, and relationship to 
chimpanzee foamy viruses. Journal of lnfectious Diseases 137, 
412-427. 
BURNETIE, B., Yu, G. & FESTED, R. L. (1993). Phosphorylation of 
HIV-1 gag proteins by protein kinase C. Journal of Biologica/ 
Chemistry 12, 8698-8703. 
CAMERON, K. R., BIRCHALL, S. M. & MOSES, M. A. (1978).1solation of 
foamy virus from patient with dialysis encephalopathy. Lancet ii, 
796. 
CHIRGWIN, J. M., PRzYBLA, A. E., MACDoNALD, R. J. & RuTTER, 
W. J. (1979). Isolation of biologically active ribonucleic acid from 
sources enriched in ribonuclease. Biochemistry 18, 5294-5299. 
CoFFIN, J. (1990). Retroviridae and their replication. In Viro/ogy, vol. 
2, pp. 1437-1500. Edited byB. N. Fields &D. M. Knipe. NewYork: 
Raven Press. 
CuLLEN, B. R. (1991). Human immundeficiency virus as a prototypic 
complex. retrovirus. Journal of Virology 65, 1053-1056. 
DANIEL, M. 0., LETVIN, N. L., KINO, N. W., KANNAGI, M., SEHOAL, 
P. K., HUNT, R. 0., K.ANKI, P. J., EssEx, M. & DESROSIERS, R. C. 
(1985). Isolation of T-cell tropic HTLV-III-1ike retrovirus from 
macaques. Science 228, 1201-1204. 
ELLINGER, S., GLOCKSHUBER, R., JAHN, G. & PLÜCKTHUN, A. (1989). 
Cleavage of procaryotically expressed human immunodeficiency 
virus fusion proteins by factor Xa and application in Western b1ot 
(immunoblot) assays. Journal of Clinical Microbiology 21, 971-976. 
EssEx, M., ALLAN, J., KANKI, P., MCLANE, M. F., MALONE, G., 
KITCHEN, L. & LEE, T. H. (1985). Antigens ofhuman T-lymphotropic 
virus type III/1ymphadenopathy-associated virus. Annals of Interna/ 
Medicine 103, 70(}.-703. 
FLÜGEL, R. M. (1993). Th.e mo1ecu1ar biology of the human spuma-
virus. In Human Retroviruses- Frontiers in Molecu/ar Biology, pp. 
193-214. Edited by B. R. Cullen. Oxford: Oxford University Press. 
FLÜGEL, R. M., RETHWILM, A., MAURER, B. & 0ARAJ, G. (1987). 
Nucleotide sequence analysis of the env gene and its flanking regions 
of the human spumaretrovirus reveals two novel genes. EM BO 
Journa/6, 2077-2084. 
FLÜGEL, R. M., RETHwiLM, A., MAUERER, B. & DARAI, G. (1990). 
Nucleotide sequence analysis ofthe env gene and its Bankingregions 
of the human spumaretrovirus reveals two novel genes (Corri-
gendum). EMBO Journa/9, 3806. 
GAINES, H., SÖNNERBORG, A., CZAJKOWSKI, J., CHIODI, F., FENYÖ, E. 
M., VON SYDOW, M., ALBERT, J., PEHRSON, P. 0., MOBERG, L., As.Jö, 
B. & FoRSGREN, M. (1987). Antibody responsein primary human 
immunodeficiency virus infection. Lancet i, 1249-1253. 
GIRON, M. L., ROZAIN, F., DEBONS-GUILLEMIN, M.-C., CANIVET, M., 
PERIES, J. & EMANOIL-RAVWR, R. (1993). Human foamy virus 
polypeptides: identification of env and bei gene products. Journal of 
Virology 61, 3596-3600. 
GRUNSTEIN, M. & HOGNESS, 0. (1975). Colony hybridization: a 
method for the isolation of cloned ONAs that contain a specific gene. 
Proceedings of the National Academy of Sciences, U.S.A. 72, 
3961-3965. 
GUBLER, U. & HOFMAN, B. J. (1983). A simple and very efficient 
method for generating cDNA libraries. Gene 25, 263-269. 
HERCHENRÖDER, 0., RENNE, R., LoNCAR, D., COBB, E. K., MURTHY, 
K. K., SCHNEIDER, J., MERGIA, A. & LUCIW, P. A. (1994). Isolation, 
cloning, and sequencing of simian foamy virus from chimpanzees 
(SFVcpz): high homology to human foamy virus (HFV). Virology 
201, 187-199. 
HooKS, J. J. & GrBBS, C. J. (1975). The foamy viruses. Bacterio/ogical 
Reviews 39, 169-185. 
HOOKS, J. J. & DETRICK-HOOKS, B. (1981). Spumavirinae: foamy virus 
group infections: comparative aspects and diagnosis. In Comparative 
Diagnosis ofViral Diseases, pp. 599-618. Edited by K. Kurstak & C. 
Kurstak. San Diego: Academic Press. 
KUPUEC, J.-J., KAY, A., HAYAT, M., RA VIER, R., PERIES, J. & GALIBERT, 
F. (1991). Sequence analysis of the simian foamy virus type 1 
genome. Gene 101, 185-194. 
LEIS, 1., PHILLIPS, N., Fu, X., TUAZON, P. & TRAUGH, J. A. (1989). 
Phosphorylation of avian retrovirus matrix protein by Ca2+ f 
phospholipid-dependent protein kinase. European Journal of Bio-
chemistry 179, 415-422. 
LIVINGSTONE, C. & JoNES, I. (1989). Baculovirus expression vectors 
with singlestrand capability. Nucleic Acids Research 17, 2366. 
LöCHELT, M., ZENTGRAF, H. & FLÜGEL, R. M. (1991). Construction of 
an infectious DNA clone of the full-length human spumaretrovirus 
genome and mutagenesis of the bei 1 gene. Virology 184, 43-54. 
LöCHELT, M., MURANYI, W. & FLÜGEL, R. M. (1993). Human foamy 
virus genome possesses an intema\, Bel-1-dependent and functional 
promoter. Proceedings of the National Academy of Sciences, U.S.A. 
90, 7317-7321. 
LöcHELT, M., FLÜGEL, R. M. & ABOUD, M. (1994). The human foamy 
virus intemal promoter directs the expression of the functional bel 1 
transactivator and bet protein ear1y after infection. Journal of 
Virology 68, 638-645. 
LoH, P. C. (1993). Spumavirinae. In The Retroviridae, pp. 361-397. 
Edited by J. A. Levy. New York: Plenum Press. 
LoH, P. C., MATSUURA, F. & MIZUMOTO, C. (1980). Seroepidemiology 
Foamy virus Gag and Bet proteins 2643 
of human syncytial virus: antibody prevalence in the Pacific. 
lntervirology 13, 87-90. 
MAHNKE, C., LöcHELT, M., BANNERT, H. & FLÜGEL, R. M. (1990). 
Specific enzyme-linked immunosorbent assay for the detection of 
antibodies to the human spumavirus. Journal of Virological Methods 
29, 13-22. 
MAHNKE, C., KAsHAIYA, P., RÖSSLER, J., BANNERT, H., LEVIN, A., 
BLATTNER, w. A., DIETRICH, M., LUANDE, J., LöcHELT, M., 
FRIEDMAN-KIEN, A. E., KoMAROFF, A. L., LoH, P. C., WESTARP, M.-
E. & FLÜGEL, R. M. (1992). Human spumarvirus antiborlies in sera 
from African patients. Archives of Virology 123, 243-253. 
MATSUURA, Y., POSSEE, R. 0., ÜVERTON, H. A. & BISHOP, D. H. L. 
(1987). Baculovirus expression vectors: the requirements for high 
Ievel expression of proteins, including glycoproteins. Journal of 
General Virology 68, 1233-1250. 
MAURER, B., BANNERT, H., DARAI, G. & FLÜGEL, R. M. (1988). 
Analysis of the primary structure of the long terminal repeat and the 
gag and pol genes ofthe human spumaretrovirus. Journal ofVirology 
62, 159(}.-1597. 
MERGIA, A. (1994). Simian foamy virus type 1 contains a second 
promoter located at the 3' end of the env gene. Virology 199, 
219-222. 
MERGIA, A. & Lucrw, P. (1991). Replication and regulation ofprimate 
foamy viruses. Viro/ogy 184, 475-482. 
MERGIA, A., SHAW, K. E. S., LACKNER, J. E. & LuciW, P. (1990). 
Relationship of the env genes and the endonuclease domain of the 
pol genes of sirnian foamy virus type 1 and human foamy virus. 
Journal of Virology 64, 406-410. 
MERGIA, A., SHAW, K. E. s., PRATT-LOWE, E., BARRY, P. A. & LUCIW, 
P. (1991). Jdentification of the simian foamy virus transcriptional 
transactivator gene (tat). Journal of Virology 65, 2903-2909. 
MULLER, H. K., BALL, G., EPSTEIN, M. A., ACHONG, 8. G., LENOIR, G. 
& LEVIN, A. (1980). The preva1ence ofnaturally occurring antibodies 
to human syncytial virus in East African populations. Journal of 
General Virology 41, 399-406. 
NEMO, G. J., BROWN, P. W., GIBBS, C. J. & GAJDUSEK, 0. C. (1978). 
Antigenie relationship of human foamy virus to the simian foamy 
viruses. lnfection and lmmunity 20, 69-72. 
NETZER, K.-0., RETHWILM, A., MAURER, B. & TER MEULEN, V. (1990). 
ldentification of the major immunogenic structural proteins of 
human foamy virus. Journal of General Virology 71, 1237-1241. 
NETZER, K.-0., SCHLIEPHAKE, A., MAURER, B., WATANABE, R., 
AGUZZI, A. & RETHWILM, A. (1993). ldentification of pol-related 
gene products of human foamy virus. Virology 192, 336-338. 
NEUMANN-HAEFELIN, 0., RlmiWILM, A., BAUER, G., GUDAT, F. & ZUR 
HAUSEN, H. (1983). Characterization of a foamy virus isolated from 
Cercopithecus aethiops lymphoblastoic cells. Medical Microbiology 
and Immunology 172, 75-86. 
NEUMANN-HAEFELIN, 0., FLEPS, U., RENNE, R. & SCHWEIZER, M. 
(1993). Foamy viruses. Jntervirology 35, 196-207. 
PossEE, R. 0. & HowARD, S. C. (1987). Analysis ofthe polyhedrin gene 
promoter of the Autographa ca/ifornica nuclear polyhedrosis virus. 
Nucleic Acids Research 15, 10233-10248. 
RENNE, R., FRIEDL, E., SCHWEIZER, M., FLEPS, u., TuREK, R. & 
NEUMANN-HAEFELIN, 0. (1992). Genomic organization and ex-
pression of simian foamy virus type 3 (SFV -3). Virology 186, 
597-608. 
RETHWILM, A. (1994). Regulation of foamy virus gene expression. 
Current Topics in Microbiology and lmmunology (in press). 
RETHWILM, A., BAUNACH, G., NETZER, K.-0., MAURER, B., BoRISCH, 
B. & TER MEULEN, V. (1990). lnfectious DNA of the human 
spumaretrovirus. Nucleic Acids Research 18, 733-738. 
RETHWILM, A., ERLWEIN, 0., BAUNACH, G.. MAURER, B. & TER 
MEULEN, V. (1991). The transcriptional transactivator of human 
foamy virus maps to the bell genomic region. Proceedings of ehe 
National A.cademy of Sciences, U.S.A. 88, 941-945. 
SANGER, F., NICKLEN, S. & COULSON, A. R. (1977). DNA sequencing 
with chain-terminating inhibitors. Proceedings of the National 
Academy of Sciences, U.S.A. 14, 5463-5467. 
ScHLIEPHAKE, A. W. & RErHWILM, A. (1994). Nuclear localization of 
foamy virus gag precursor protein. Journal of Virology 68, 
4946-4956. 
2644 H. Hahn and others 
SCHOCHETMAN, G., EPSTEIN, J. S. & ZucK., T. F. (1989). Serodiagnosis 
of infection with the AIDS virus and other human retroviruses. 
Annual Review of Microbiology 43, 629-659. 
SMITH, D. 8. & JOHNSON, K. S. (1988). Single-step purification of 
polypeptides expressed in Escherichia coli as fusions with glutathione 
S-transferase. Gene 57, 31-40. 
STANCEK., D., STANCEKOVA-GRESSNEROVA, M., JANOTKA, M., HNILICA, 
P. & ORAVEC, D. (1975). Isolation and some serological and 
epidemiological data on the viruses recovered from patients with 
subacute thyroiditis de Quervain. Medical Microbiology and lm-
muno/ogy 161, 133-144. 
TEICH, N. (1984). Taxonomy of retroviruses. In RNA Tumor Viruses 
vol. I, pp. 25-207. Edited by R. Weiss, N. Teich, H. Varmus & J: 
Coffin. New York: Cold Spring Harbor Laboratory. 
VAISHNAV, Y. N. & WoNG-STAAL, F. (1991). The biochemistry of 
AIDS. Annual Review of Biochemistry 60, 577-630. 
VENKATESH, L. K., y ANG, c., THEODORAKIS, P. A. & CHJNNADURAI, G. 
(1993). Functional dissection of the human spumaretrovirus trans-
activator identifies distinct classes of dominant-negative mutants. 
Journal of Virology 67, 161-169. 
WERNER, J. & GELDERBLOM, H. (1979). Isolation of foamy virus from 
patient with de Quervain thyroiditis. Lancet ii, 258-259. 
WESTARP, M. E., KORNHUBER, H. H., RössLER, J. & FLÜGEL, R. M. 
(1992). Human spumaretrovirus antibodies in amyotrophic lateral 
sclerosis. Neurology, Psychiatry and Brain Research l, 1-4. 
WICK, G., TRIEB, K., AGUZZI, A., RECHEIS, H.~ ANDERL, H. & 
GRUBECK-LoEBENSTEIN, B. (1993). Possible rote of human foamy 
virus in Graves' disease. lntervirology 35, 101-107. 
YOUNG, D., SAMUELS, J. & CLAltKE, J. K. (1973). A foamy virus of 
possible human origin isolated in BHK-21 cells. Archiv für die 
Gesamte Virusforschung 42, 228-234. 
Yu, S. F. & LINIAL, M. (1993). Analysis of the role of the bei and bet 
open reading frames of human foamy virus by using a new 
quantitative assay. Journal of Virology 67, 6618-6624. 
(Received lJ February 1994; Accepted 6 May 1994) 
